{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:44:35Z","timestamp":1775580275462,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFD0502200"],"award-info":[{"award-number":["2017YFD0502200"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.vaccine.2018.07.054","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T19:08:24Z","timestamp":1533150504000},"page":"5591-5599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime\u2013protein boost regimen against bovine viral diarrhea virus"],"prefix":"10.1016","volume":"36","author":[{"given":"Dongjie","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanjiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.054_b0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.prevetmed.2005.08.018","article-title":"Quantification of economic losses consecutive to infection of a dairy herd with bovine viral diarrhoea virus","volume":"72","author":"Fourichon","year":"2005","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2018.07.054_b0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.vetmic.2009.09.022","article-title":"Clinical appearance and pathology of cattle persistently infected with bovine viral diarrhoea virus of different genetic subgroups","volume":"141","author":"Bachofen","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cvfa.2009.10.007","article-title":"Bovine viral diarrhea virus: global status","volume":"26","author":"Ridpath","year":"2010","journal-title":"Vet Clin Food Anim"},{"key":"10.1016\/j.vaccine.2018.07.054_b0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1045-1056(03)00030-7","article-title":"Economic impact of BVDV infection in dairies","volume":"31","author":"Houe","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.07.054_b0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1079\/AHR2005102","article-title":"BVD control in Europe: current status and perspectives","volume":"6","author":"Moennig","year":"2005","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2018.07.054_b0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tvjl.2008.11.014","article-title":"Control of bovine virus diarrhoea at the herd level: reducing the risk of false negatives in the detection of persistently infected cattle","volume":"184","author":"Laureyns","year":"2010","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2018.07.054_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.biologicals.2012.07.003","article-title":"Immunology of BVDV vaccines","volume":"41","author":"Ridpath","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.07.054_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S1466252315000043","article-title":"Perspective on BVDV control programs","volume":"16","author":"Givens","year":"2015","journal-title":"Anim Health Res Rev"},{"key":"10.1016\/j.vaccine.2018.07.054_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biologicals.2012.07.002","article-title":"Molecular biology of bovine viral diarrhea virus","volume":"41","author":"Neill","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.07.054_b0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1045-1056(03)00021-6","article-title":"Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes","volume":"31","author":"Fulton","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.07.054_b0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-1702(98)00095-1","article-title":"Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization","volume":"57","author":"Deregt","year":"1998","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.07.054_b0060","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1016\/j.vaccine.2007.05.036","article-title":"Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation","volume":"25","author":"Liang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.054_b0065","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1016\/j.vaccine.2005.06.025","article-title":"Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses","volume":"23","author":"Liang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.054_b0070","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1016\/j.vaccine.2015.06.017","article-title":"Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves","volume":"33","author":"El-Attar","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.054_b0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11259-012-9526-x","article-title":"Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle","volume":"36","author":"Pecora","year":"2012","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2018.07.054_b0080","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.vaccine.2014.10.010","article-title":"The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle","volume":"32","author":"Snider","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.054_b0085","doi-asserted-by":"crossref","first-page":"6617","DOI":"10.1039\/C4NR01202J","article-title":"In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles","volume":"6","author":"Mahony","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.vaccine.2018.07.054_b0090","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.054_b0095","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1099\/vir.0.81737-0","article-title":"Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from bovine viral diarrhea virus in cattle","volume":"87","author":"Liang","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0100","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1099\/jgv.0.000863","article-title":"DNA prime\/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant","volume":"98","author":"Menon","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0105","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/S0264-410X(01)00157-8","article-title":"Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice","volume":"19","author":"Nobiron","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.054_b0110","doi-asserted-by":"crossref","first-page":"e1004828","DOI":"10.1371\/journal.ppat.1004828","article-title":"A two-component DNA-prime\/protein-boost vaccination strategy for eliciting long-term, protective T cell Immunity against Trypanosoma cruzi","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.07.054_b0115","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1128\/JVI.01458-16","article-title":"Fc receptor-mediated activities of Env-specific human monoclonal antibodies generated from volunteers receiving the DNA Prime-Protein boost HIV Vaccine DP6-001","volume":"90","author":"Costa","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/sji.12279","article-title":"71 VG is advantageous to Freund's adjuvant in immunization against S. aureus infection of mice","volume":"81","author":"Klimka","year":"2015","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0125","doi-asserted-by":"crossref","first-page":"P428","DOI":"10.1186\/2051-1426-3-S2-P428","article-title":"Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines","volume":"3","author":"Ascarateil","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.vaccine.2018.07.054_b0130","doi-asserted-by":"crossref","unstructured":"Ibrahim Eel-S, Gamal WM, Hassan AI, Mahdy Sel-D, Hegazy AZ, Abdel-Atty MM. Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine. Vet World 2015;8:1189\u201398.","DOI":"10.14202\/vetworld.2015.1189-1198"},{"key":"10.1016\/j.vaccine.2018.07.054_b0135","first-page":"8","article-title":"Evaluation of the efficacy of a new oil-based adjuvant ISA 61 VG FMD vaccine as a potential vaccine for cattle","volume":"17","author":"Khorasani","year":"2016","journal-title":"Iran J Vet Res"},{"key":"10.1016\/j.vaccine.2018.07.054_b0140","doi-asserted-by":"crossref","first-page":"e106891","DOI":"10.1371\/journal.pone.0106891","article-title":"Generation and efficacy evaluation of recombinant classical swine fever virus E2 glycoprotein expressed in stable transgenic mammalian cell line","volume":"9","author":"Hua","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.054_b0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4142\/jvs.2015.16.4.491","article-title":"Genetic characterization of bovine viral diarrhea virus strains in Beijing, China and innate immune responses of peripheral blood mononuclear cells in persistently infected dairy cattle","volume":"16","author":"Weng","year":"2015","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2018.07.054_b0150","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1007\/s00705-016-3055-9","article-title":"Genomic characterization of three bovine viral diarrhea virus isolates from cattle","volume":"161","author":"Cai","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0155","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00705-015-2412-4","article-title":"Experimental infection of mice with bovine viral diarrhea virus","volume":"160","author":"Seong","year":"2015","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.virusres.2005.05.011","article-title":"The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus","volume":"114","author":"Pande","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.07.054_b0165","doi-asserted-by":"crossref","first-page":"e87837","DOI":"10.1371\/journal.pone.0087837","article-title":"Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge","volume":"9","author":"De Filette","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.054_b0170","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1080\/21645515.2017.1380137","article-title":"Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines","volume":"13","author":"Wang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.07.054_b0175","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1016\/j.vaccine.2008.03.089","article-title":"The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination","volume":"26","author":"Su","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.054_b0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cimid.2007.06.006","article-title":"Bovine viral diarrhea viruses modulate toll-like receptors, cytokines and co-stimulatory molecules genes expression in bovine peripheral blood monocytes","volume":"31","author":"Lee","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.054_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biologicals.2012.09.009","article-title":"The impact of BVDV infection on adaptive immunity","volume":"41","author":"Chase","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.07.054_b0190","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.07.054_b0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.dci.2011.10.009","article-title":"Yeast-surface expressed BVDV E2 protein induces a Th1\/Th2 response in na\u00efve T cells","volume":"37","author":"Patterson","year":"2012","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imr.12426","article-title":"CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity","volume":"272","author":"Bedoui","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2018.07.054_b0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.07.054_b0210","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.vaccine.2009.02.010","article-title":"Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus","volume":"27","author":"Thomas","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:17Z","timestamp":1759400837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18310612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0264410X18310612"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime\u2013protein boost regimen against bovine viral diarrhea virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}